Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells

scientific article published on May 15, 1991

Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1991PNAS...88.4153S
P356DOI10.1073/PNAS.88.10.4153
P953full work available at URLhttps://europepmc.org/articles/PMC51616
https://europepmc.org/articles/PMC51616?pdf=render
https://pnas.org/doi/pdf/10.1073/pnas.88.10.4153
P932PMC publication ID51616
P698PubMed publication ID1851995
P5875ResearchGate publication ID21303979

P50authorAndrew SchallyQ141147
P2093author name stringA. V. Schally
K. Lapis
J. D. Neill
B. Szende
J. Timar
J. J. Mulchahey
G. Srkalovic
A. Csikos
K. Szepeshazi
P2860cites workA study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidQ26778512
Subcellular localization of the receptor for gonadotropin-releasing hormone in pituitary and ovarian tissueQ28565420
Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormoneQ33841289
Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormoneQ34598135
Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.Q36245969
Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonistsQ46687762
Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*Q58854013
Luteinizing hormone-releasing hormone (LH-RH) binding to purified rat pituitary nucleiQ58854059
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistQ59065919
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cellsQ63359359
Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regressionQ68089195
Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75Q68451778
Cultured mammary carcinoma cells contain gonadotropin-releasing hormone-like immunoreactivity, GnRH binding sites and chorionic gonadotropinQ68943980
Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasiaQ69076825
Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?Q69118398
Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancerQ69370646
Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancerQ69372214
Membrane receptors for peptides in experimental and human pancreatic cancersQ69375881
Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinomaQ69377509
Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatinQ69377991
Gonadotropin-releasing hormone binding sites in human breast carcinomaQ70094439
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)4153-4156
P577publication date1991-05-01
1991-05-15
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleLocalization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells
P478volume88

Reverse relations

cites work (P2860)
Q102995406A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer
Q48002807A somatostatin analogue induces translocation of Ku 86 autoantigen from the cytosol to the nucleus in colon tumour cells
Q77994303A specifically radiolabeled somatostatin analog with strong antitumor activity induces apoptosis and accumulates in the cytosol and the nucleus of HT29 human colon carcinoma cells
Q40970844A study on liposomal encapsulation of a lipophilic prodrug of LHRH.
Q33894753Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix
Q35975764Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone
Q38980206LHRH-Targeted Drug Delivery Systems for Cancer Therapy.
Q61838848Localization of luteinizing-hormone releasing hormone binding sites in the gastric mucosa of suckling rats
Q57555436Localization of the three GnRH types and GnRH receptors in the brain of a cichlid fish: Insights into their neuroendocrine and neuromodulator functions
Q37724516Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors
Q40915919Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature
Q44499115Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer
Q41041858Signal transduction of the gonadotropin releasing hormone (GnRH) receptor: cross-talk of calcium, protein kinase C (PKC), and arachidonic acid
Q57105900Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer

Search more.